{"id":612125,"date":"2025-09-10T17:49:43","date_gmt":"2025-09-10T09:49:43","guid":{"rendered":"https:\/\/law.asia\/?p=612125"},"modified":"2025-10-16T11:14:37","modified_gmt":"2025-10-16T03:14:37","slug":"china-pharma-out-licensing-deals","status":"publish","type":"post","link":"https:\/\/law-asia.visibleone.dev\/zh-hans\/china-pharma-out-licensing-deals\/","title":{"rendered":"\u201c\u836f\u201d\u8dc3\u9f99\u95e8"},"content":{"rendered":"

\u968f\u7740\u9876\u5c16\u4e2d\u56fd\u836f\u4f01\u4ece\u4eff\u5236\u836f\u5411\u521b\u65b0\u836f\u6218\u7565\u8f6c\u578b\uff0c\u5bf9\u5916\u6388\u6743\uff08<\/strong>license-out<\/strong>\uff09\u4ea4\u6613\u5df2\u6210\u4e3a\u5546\u52a1\u62d3\u5c55\u7684\u6838\u5fc3\u3002\u5728\u4e2d\u56fd\u836f\u4f01\u4e0e\u5168\u7403\u5de8\u5934\u4ea4\u6613\u7684\u6d6a\u6f6e\u4e2d\uff0c\u4f01\u4e1a\u8be5\u5982\u4f55\u89c4\u907f\u77e5\u8bc6\u4ea7\u6743\u3001\u6570\u636e\u8de8\u5883\u3001\u53cd\u5784\u65ad\u7533\u62a5\u4e2d\u7684\u6f5c\u5728\u9677\u9631\uff0c\u786e\u4fdd\u4ea4\u6613\u771f\u6b63\u6210\u529f\uff1f<\/strong><\/em><\/span>\u83ab\u6893\u6eb5<\/strong><\/em>\u62a5\u9053<\/strong><\/em><\/span><\/p>\n

\u5c31\u5728\u672a\u6765\u4e24\u5230\u4e09\u5e74\u5185\uff0c\u5168\u7403\u5236\u836f\u5de8\u5934\u5373\u5c06\u9762\u4e34”\u4e13\u5229\u60ac\u5d16”\u7684\u4e25\u5cfb\u6311\u6218\uff0c\u6570\u4ee5\u767e\u4ebf\u7f8e\u5143\u8ba1\u7684\u660e\u661f\u836f\u7269\u5c06\u8fce\u6765\u4eff\u5236\u836f\u7684\u6fc0\u70c8\u7ade\u4e89\u3002\u9762\u5bf9\u91cd\u91cd\u538b\u529b\u7684\u8de8\u56fd\u836f\u4f01\uff0c\u4e0d\u7ea6\u800c\u540c\u5730\u5c06\u76ee\u5149\u6295\u5411\u4e86\u4e1c\u65b9\u2014\u2014\u5728\u4e2d\u56fd\u641c\u5bfb\u4e0b\u4e00\u4ee3\u201c\u91cd\u78c5\u70b8\u5f39\u836f\u7269\u201d\uff08blockbuster drug\uff09\uff0c\u5e76\u79ef\u6781\u6536\u8d2d\u65e9\u671f\u4e34\u5e8a\u9636\u6bb5\u7684\u521b\u65b0\u836f\u7269\u3002<\/p>\n

\u9a71\u52a8\u8fd9\u4e00\u6218\u7565\u8f6c\u5411\u7684\uff0c\u4e0d\u4ec5\u662f\u4e2d\u56fd\u836f\u7269\u7814\u53d1\u80fd\u529b\u7684\u663e\u8457\u63d0\u5347\uff0c\u8fd8\u6709\u65e5\u76ca\u6210\u719f\u7684\u533b\u836f\u4f9b\u5e94\u94fe\u4f53\u7cfb\u3002<\/p>\n

\u4eca\u5e74\u4e0a\u534a\u5e74\u8fce\u6765\u4e24\u4e2a\u521b\u7eaa\u5f55license-out\u4ea4\u6613\uff0c\u4e09\u751f\u5236\u836f\u57285\u6708\u4e0e\u7f8e\u56fd\u533b\u836f\u5de8\u5934\u8f89\u745e\u516c\u53f8\u8fbe\u621012.5\u4ebf\u7f8e\u5143\u9996\u4ed8\u6b3e\uff0c\u5237\u65b0\u4e86\u56fd\u4ea7\u521b\u65b0\u836flicense-out\u7684\u6700\u9ad8\u9996\u4ed8\u6b3e\u8bb0\u5f55\u3002\u800c\u4e2d\u56fd\u201c\u533b\u836f\u4e00\u54e5\u201d\u6052\u745e\u533b\u836f\u57287\u6708\u4e0e\u82f1\u56fd\u5236\u836f\u5de8\u5934\u845b\u5170\u7d20\u53f2\u514b\uff08GSK\uff09\u8fbe\u6210\u521b\u7eaa\u5f55\u7684120\u4ebf\u7f8e\u5143\u5bf9\u5916\u6388\u6743\u5408\u4f5c\u4ea4\u6613\uff0c\u53cc\u65b9\u5c06\u5171\u540c\u5f00\u53d1\u81f3\u591a12\u6b3e\u521b\u65b0\u836f\u3002<\/p>\n

\u8fd9\u53ea\u4e0d\u8fc7\u662f\u51b0\u5c71\u4e00\u89d2\u2014\u2014\u6839\u636e\u533b\u836f\u9b54\u65b9\u7684\u516c\u5f00\u6570\u636e\uff0c\u4eca\u5e74\u4e0a\u534a\u5e74\u4e2d\u56fdlicense-out\u4ea4\u6613\u9ad8\u8fbe72\u5b97\uff0c\u5df2\u8fbe\u53bb\u5e74\u5168\u5e74\u768476%\u3002\u4ece2021\u5e74\u52302024\u5e74\uff0c\u4ea4\u6613\u6570\u91cf\u4ece50\u5b97\u589e\u81f394\u5b97\uff0c\u589e\u957f88%\uff1b\u603b\u91d1\u989d\u5219\u4ece\u4e5d\u4ebf\u7f8e\u5143\u8dc3\u81f3519\u4ebf\u7f8e\u5143\uff0c\u6da8\u5e45\u8d8557\u500d\u3002<\/p>\n

\u5728\u533b\u836f\u884c\u4e1a\u62e5\u670916\u5e74\u4ece\u4e1a\u7ecf\u9a8c\u3001\u9a7b\u9999\u6e2f\u7684\u897f\u76df\u65af\u5f8b\u5e08\u4e8b\u52a1\u6240\u5927\u4e2d\u534e\u533a\u533b\u7597\u4fdd\u5065\u4e0e\u751f\u547d\u79d1\u5b66\u4e1a\u52a1\u4e3b\u7ba1\u674e\u7a0b\u8bf4\uff0c\u8fd9\u4e00\u6ce2\u6d6a\u6f6e\u7684\u6839\u6e90\u59cb\u4e8e2022\u5e74\uff0c\u533b\u836f\u4f01\u4e1a\u53d7\u5230\u8d44\u672c\u5e02\u573a\u5927\u73af\u5883\u7684\u5f71\u54cd\uff0c\u5bfc\u81f4\u5c1a\u672a\u5b9e\u73b0\u76c8\u5229\u7684\u4f01\u4e1a\u666e\u904d\u9762\u4e34\u4e00\u4e8c\u7ea7\u5e02\u573a\u6d41\u52a8\u6027\u964d\u4f4e\u4e0e\u878d\u8d44\u6e20\u9053\u6536\u7a84\u7684\u56f0\u5883\uff0c\u8feb\u4f7f\u591a\u5bb6\u836f\u4f01\u4e0d\u5f97\u4e0d\u51fa\u8ba9\u624b\u4e2d\u201c\u5b9d\u8d1d\u201d\u521b\u65b0\u836f\u7684\u90e8\u5206\u6743\u76ca\uff0c\u4ee5\u6362\u53d6\u7ef4\u6301\u4f01\u4e1a\u7814\u53d1\u548c\u8fd0\u8425\u6240\u9700\u7684\u8d44\u91d1\u3002<\/p>\n

\u800c\u8fd9\u4e00\u52a8\u5411\uff0c\u6070\u4e0e\u5927\u578b\u6b27\u7f8e\u836f\u4f01\u7684\u6218\u7565\u9700\u6c42\u76f8\u5951\u5408\u3002\u4e2d\u56fd\u65e5\u8d8b\u6210\u719f\u7684\u533b\u836f\u7814\u53d1\u4f9b\u5e94\u94fe\u548c\u836f\u4f01\u6301\u7eed\u4ea7\u51fa\u9ad8\u8d28\u91cf\u65e9\u671f\u4e34\u5e8a\u6570\u636e\u7684\u80fd\u529b\uff0c\u4e5f\u5438\u5f15\u7740\u8de8\u56fd\u4f01\u4e1a\u52a0\u5927\u5bf9\u4e2d\u56fd\u521b\u65b0\u836f\u2160\u548c\u2161\u671f\u4e34\u5e8a\u8d44\u4ea7\u7684\u6536\u8d2d\u3002<\/p>\n

\"Zhu-min\"<\/p>\n

\u4eca\u5e74\uff0c\u534f\u52a9\u845b\u5170\u7d20\u53f2\u514b\u4ee5\u53ca\u4e09\u751f\u5236\u836f\u5b8c\u6210\u91cd\u78c5\u4ea4\u6613\u7684\u6c49\u5764\u5f8b\u5e08\u4e8b\u52a1\u6240\u9a7b\u4e0a\u6d77\u7684\u5408\u4f19\u4eba\u6731\u654f\u8bf4\uff0c\u4e0e\u6b64\u524d\u56fd\u5185\u8f83\u4e3a\u666e\u904d\u7684license-in\uff08\u6388\u6743\u5f15\u8fdb\uff09\u6a21\u5f0f\u76f8\u6bd4\uff0clicense-out\u4ea4\u6613\u5f80\u5f80\u66f4\u4e3a\u590d\u6742\u3002License-out\u4e0d\u4ec5\u6d89\u53ca\u4ea4\u6613\u8c08\u5224\u3001\u7a0e\u52a1\u4e0e\u8d44\u91d1\u7b79\u5212\u3001\u77e5\u8bc6\u4ea7\u6743\u4fdd\u62a4\u3001\u53cd\u5784\u65ad\u7533\u62a5\u3001\u6570\u636e\u8de8\u5883\u5408\u89c4\uff0c\u8fd8\u53ef\u80fd\u7275\u6d89\u4e0a\u5e02\u516c\u53f8\u7684\u516c\u53f8\u6cbb\u7406\u4e0e\u4fe1\u606f\u62ab\u9732\u7b49\u591a\u6cd5\u5f8b\u9886\u57df\u7684\u4ea4\u53c9\u95ee\u9898\u3002\u5f00\u5c55\u4ea4\u6613\u65f6\uff0c\u533b\u836f\u4f01\u4e1a\u9700\u8981\u5168\u65b9\u4f4d\u7684\u6cd5\u5f8b\u670d\u52a1\u652f\u6491\u548c\u4fdd\u969c\u3002<\/p>\n

\u6731\u654f\u8bf4\uff1a\u201c\u4ece\u516c\u4f17\u89c6\u89d2\u6765\u770b\uff0c\u5408\u540c\u4ef7\u683c\uff0c\u5c24\u5176\u662f\u9996\u4ed8\u6b3e\u91d1\u989d\uff0c\u5f80\u5f80\u6700\u53d7\u5173\u6ce8\u3002\u4f46\u4ece\u4ea4\u6613\u6587\u4ef6\u8c08\u5224\u7684\u4e13\u4e1a\u89c6\u89d2\u6765\u770b\uff0clicense-out\u534f\u8bae\u4e2d\u5e76\u4e0d\u5b58\u5728\u53ef\u4ee5\u88ab\u2018\u5ffd\u89c6\u2019\u7684\u6761\u6b3e\u2014\u2014\u6bcf\u4e00\u6761\u90fd\u53ef\u80fd\u5728\u9879\u76ee\u751f\u547d\u5468\u671f\u5185\u4ea7\u751f\u91cd\u5927\u5f71\u54cd\u3002\u201d<\/p>\n

\u4ef7\u683c\u4e4b\u5916\u7684\u91cd\u70b9<\/strong><\/span><\/h2>\n

\u4ee5\u201c\u9648\u8ff0\u3001\u4fdd\u8bc1\u4e0e\u627f\u8bfa\u201d\u6761\u6b3e\u4e3a\u4f8b\uff0c\u6731\u654f\u8bf4\u5f88\u591a\u975e\u6cd5\u5f8b\u80cc\u666f\u4eba\u58eb\u4f1a\u5c06\u5176\u89c6\u4e3a\u683c\u5f0f\u5316\u6761\u6b3e\uff0c\u5b9e\u9645\u4e0a\u5f53\u4e2d\u6db5\u76d6\u4e86\u4ea4\u6613\u53cc\u65b9\u5728\u4e1a\u52a1\u4e8b\u5b9e\u3001\u5408\u89c4\u72b6\u6001\u3001\u6301\u7eed\u4e49\u52a1\u7b49\u591a\u65b9\u9762\u7684\u63cf\u8ff0\u4e0e\u627f\u8bfa\u3002\u201c\u56e0\u6b64\uff0c\u5728\u8c08\u5224\u4e2d\u5fc5\u987b\u7ed9\u4e88\u8fd9\u4e9b\u6761\u6b3e\u4e0e\u4ef7\u683c\u6761\u6b3e\u540c\u7b49\u7684\u5173\u6ce8\uff0c\u5fc5\u8981\u65f6\u901a\u8fc7\u9650\u5b9a\u8303\u56f4\u3001\u660e\u786e\u4f8b\u5916\u3001\u5206\u914d\u8d23\u4efb\u7b49\u65b9\u5f0f\u964d\u4f4e\u672a\u6765\u4e89\u8bae\u98ce\u9669\u3002\u201d<\/p>\n

\u66fe\u5728\u6052\u745e\u533b\u836f\u7684license-out\u4ea4\u6613\u4e2d\u62c5\u4efb\u7275\u5934\u5f8b\u5e08\u7684\u79d1\u5f8b\u5f8b\u5e08\u4e8b\u52a1\u6240\u9a7b\u7ebd\u7ea6\u5408\u4f19\u4eba Alan Tamarelli \u8bf4\uff0c\u4e00\u4e2a\u6210\u529f\u7684\u9879\u76ee\uff0c\u4e0d\u4ec5\u4f9d\u8d56\u4e8e\u7ecf\u9a8c\u4e30\u5bcc\u7684\u5546\u52a1\u62d3\u5c55\uff08BD\uff09\u4e13\u5bb6\uff0c\u66f4\u9700\u8981\u5728\u6cd5\u5f8b\u5c42\u9762\u63d0\u524d\u505a\u597d\u77e5\u8bc6\u4ea7\u6743\u89c4\u5212\u4e0e\u5168\u7403\u5e02\u573a\u5730\u57df\u5e03\u5c40\uff0c\u8fd9\u4e24\u65b9\u9762\u7684\u51c6\u5907\u81f3\u5173\u91cd\u8981\u3002<\/p>\n

\"Alan<\/p>\n

\u4ed6\u8ba4\u4e3a\u8bb8\u53ef\u65b9\u5e94\u5bf9\u77e5\u8bc6\u4ea7\u6743\u8fdb\u884c\u9884\u524d\u5206\u6790\uff0c\u9884\u5224\u5408\u4f5c\u65b9\u4f1a\u8981\u6c42\u7684\u9648\u8ff0\u4e0e\u4fdd\u8bc1\u6761\u6b3e\u3002Tamarelli\u8bf4\uff1a\u201c\u63d0\u524d\u5b8c\u6210\u5206\u6790\u5de5\u4f5c\uff0c\u6709\u52a9\u4e8e\u786e\u4fdd\u6240\u6709\u4e0a\u6e38\u4e49\u52a1\u7684\u660e\u786e\u754c\u5b9a\uff0c\u4ee5\u53ca\u836f\u7269\u6743\u5c5e\u5728\u4ea4\u6613\u6587\u4ef6\u4e2d\u5f97\u4ee5\u6e05\u6670\u4f53\u73b0\u3002\u5728\u5c3d\u804c\u8c03\u67e5\u9636\u6bb5\uff0c\u5411\u6f5c\u5728\u5408\u4f5c\u4f19\u4f34\u5448\u73b0\u4e00\u4e2a\u7ed3\u6784\u6e05\u6670\u3001\u6613\u4e8e\u7406\u89e3\u7684\u77e5\u8bc6\u4ea7\u6743\u72b6\u51b5\u81f3\u5173\u91cd\u8981\u3002\u201d<\/p>\n

\u5728\u4e13\u5229\u65b9\u9762\uff0c\u66fe\u4e3a\u591a\u5bb6\u836f\u4f01\u4ee3\u7406\u4e13\u5229\u65e0\u6548\u3001\u884c\u653f\u8bc9\u8bbc\u4ee5\u53ca\u4fb5\u6743\u6848\u4ef6\u7684\u9053\u53ef\u7279\u5f8b\u5e08\u4e8b\u52a1\u6240\u9a7b\u5317\u4eac\u9ad8\u7ea7\u5408\u4f19\u4eba\u5218\u5143\u971e\u63d0\u9192\uff0c\u836f\u4f01\u5e94\u6ce8\u610f\u534f\u8bae\u4e2d\u5bf9\u884d\u751f\u4ea7\u54c1\u7684\u7ea6\u5b9a\u3002\u201c\u6211\u4eec\u6ce8\u610f\u5230\u6bd4\u8f83\u591a\u7684\u4e89\u8bae\u662f\u5bf9\u4e8e\u4ea7\u54c1\u6216\u8005\u6539\u8fdb\u4ea7\u54c1\u7684\u89c4\u5b9a\u4e0d\u660e\u786e\uff0c\u201d\u5979\u8bf4\u3002<\/p>\n

\u5979\u4ee5\u4e00\u8d77\u4e2d\u5916\u5408\u4f5c\u6848\u4ef6\u4e3a\u4f8b\u3002\u8be5\u6848\u7532\u4e59\u53cc\u65b9\u7ea6\u5b9a\uff0c\u5bf9\u4e8e\u6539\u8fdb\u540e\u4ea7\u54c1\u7684\u4e13\u5229\uff0c\u539f\u6743\u5229\u4eba\uff08\u7532\u65b9\uff09\u53ef\u4eab\u6709\u514d\u8d39\u4f7f\u7528\u7684\u6743\u5229\u3002\u7136\u800c\uff0c\u8be5\u6761\u6b3e\u5728\u5b9e\u9645\u6267\u884c\u4e2d\u5f15\u53d1\u4e86\u4e0a\u4e0b\u6e38\u6743\u5c5e\u51b2\u7a81\u2014\u2014\u7531\u4e8e\u6539\u8fdb\u5de5\u4f5c\u7531\u4e59\u65b9\u59d4\u6258\u7b2c\u4e09\u65b9\u5b8c\u6210\uff0c\u8be5\u7b2c\u4e09\u65b9\u6210\u4e3a\u5171\u6709\u6743\u5229\u4eba\u6216\u8005\u4e13\u5229\u6743\u4eba\u3002\u201c\u8fd9\u610f\u5473\u7740\uff0c\u7532\u65b9\u80fd\u6839\u636e\u53cc\u65b9\u5408\u540c\u7ea6\u5b9a\uff0c\u514d\u8d39\u4f7f\u7528\u8be5\u6539\u8fdb\u4ea7\u54c1\uff0c\u4e59\u65b9\u5374\u987b\u5411\u7b2c\u4e09\u65b9\u652f\u4ed8\u8d39\u7528\u3002\u201d \u56e0\u6b64\uff0c\u4e2d\u65b9\u4f01\u4e1a\u5728\u7b7e\u8ba2\u534f\u8bae\u65f6\uff0c\u9700\u5173\u6ce8\u76f8\u5173\u7684\u6cd5\u5f8b\u98ce\u9669\u3002<\/p>\n

\"Liu<\/p>\n

\u9664\u4e86\u4e13\u5229\u6761\u6b3e\u672c\u8eab\uff0c\u4ed8\u6b3e\u673a\u5236\u4e2d\u540c\u6837\u6f5c\u85cf\u98ce\u9669\u3002\u5728license-out\u4ea4\u6613\u4e2d\uff0c\u8bb8\u53ef\u65b9\u901a\u5e38\u53ef\u83b7\u5f97\u9996\u4ed8\u6b3e\u3001\u91cc\u7a0b\u7891\u4ed8\u6b3e\u4ee5\u53ca\u9500\u552e\u5206\u6210\u3002\u7136\u800c\uff0c\u56f4\u7ed5\u91cc\u7a0b\u7891\u4ed8\u6b3e\u5f80\u5f80\u5f15\u53d1\u4e89\u8bae\uff0c\u5218\u5143\u971e\u8bf4\u8fd9\u4e3b\u8981\u5728\u4e8e\u5408\u540c\u4ea7\u751f\u7ea0\u7eb7\u540e\u5df2\u652f\u4ed8\u7684\u6b3e\u9879\u662f\u5426\u9700\u9000\u8fd8\uff0c\u4ee5\u53ca\u5177\u4f53\u7684\u89e6\u53d1\u6761\u4ef6\u3002<\/p>\n

\u5979\u89e3\u91ca\u8bf4\uff1a\u201c\u82e5\u8bb8\u53ef\u534f\u8bae\u4ea7\u751f\u7ea0\u7eb7\uff0c\u4f8b\u5982\u672a\u8fbe\u5408\u540c\u7ea6\u5b9a\u7684\u6210\u5c31\u6761\u4ef6\uff0c\u6216\u8005\u836f\u7269\u672a\u80fd\u6210\u529f\u5883\u5916\u4e0a\u5e02\uff0c\u88ab\u8bb8\u53ef\u65b9\u53ef\u80fd\u4e3b\u5f20\u9000\u8fd8\u524d\u671f\u6240\u652f\u4ed8\u7684\u8d39\u7528\uff0c\u8fd9\u662f\u8bb8\u53ef\u65b9\u7b7e\u8ba2\u8bb8\u53ef\u534f\u8bae\u65f6\u9700\u8981\u786e\u4fdd\u6761\u6b3e\u8986\u76d6\u5230\u7684\u91cd\u8981\u573a\u666f\u4e4b\u4e00\u3002\u201d<\/p>\n

\u6570\u636e\u51fa\u5883\u662flicense-out\u4ea4\u6613\u4e2d\u7684\u5fc5\u8981\u4e00\u73af\u30022024\u5e743\u670822\u65e5\uff0c\u4e2d\u56fd\u7f51\u4fe1\u529e\u53d1\u5e03\u7684\u300a\u4fc3\u8fdb\u548c\u89c4\u8303\u6570\u636e\u8de8\u5883\u6d41\u52a8\u89c4\u5b9a\u300b\u5bf9license-out\u4ea4\u6613\u6709\u7740\u76f4\u63a5\u7684\u5f71\u54cd\u3002\u6731\u654f\u8bf4\u8fd9\u9879\u65b0\u89c4\u4f7f\u5f97\u51e0\u4e4e\u6240\u6709\u6d89\u53ca\u4e34\u5e8a\u8bd5\u9a8c\u6570\u636e\u7684license-out\u4ea4\u6613\u90fd\u9700\u8fdb\u884c\u6570\u636e\u51fa\u5883\u7533\u62a5\uff0c\u5e76\u9700\u8981\u4ea4\u6613\u5404\u65b9\u5728\u9879\u76ee\u8fc7\u7a0b\u4e2d\u7cfb\u7edf\u68b3\u7406\u7814\u7a76\u8005\u53ca\u53d7\u8bd5\u8005\u7684\u77e5\u60c5\u540c\u610f\u3001\u4e2a\u4eba\u4fe1\u606f\u4fdd\u62a4\u5f71\u54cd\u8bc4\u4f30\u7b49\u3002<\/p>\n

[ihc-hide-content ihc_mb_type=”show” ihc_mb_who=”1″ ihc_mb_template=”2″ ]<\/p>\n

\u4ed6\u8865\u5145\u8bf4\uff0c\u5f53\u6d89\u53ca\u57fa\u56e0\u4fe1\u606f\u548c\u6570\u636e\u65f6\uff0c\u8fd8\u9700\u901a\u8fc7\u536b\u5065\u59d4\u4f53\u7cfb\u5411\u9057\u4f20\u529e\u8fdb\u884c\u7533\u62a5\u3002\u201c\u8fd9\u4e9b\u6d41\u7a0b\u53ef\u80fd\u8017\u65f6\u8f83\u957f\uff0c\u9700\u8981\u5728\u9879\u76ee\u542f\u52a8\u9636\u6bb5\u5c31\u8fdb\u884c\u53ef\u884c\u6027\u8bc4\u4f30\u548c\u65f6\u95f4\u89c4\u5212\u3002\u201d<\/p>\n

License-out\u4ea4\u6613\u7684\u6210\u529f\u4e0e\u5426\uff0c\u5f80\u5f80\u8fd8\u53d6\u51b3\u4e8e\u5176\u662f\u5426\u6ee1\u8db3\u53cd\u5784\u65ad\u7533\u62a5\u8981\u6c42\u3002\u91d1\u675c\u5f8b\u5e08\u4e8b\u52a1\u6240\u7684\u9a7b\u5317\u4eac\u5408\u4f19\u4eba\u674e\u96e8\u6fdb\u8bf4\uff0c\u8fdb\u884c\u4ea4\u6613\u65f6\u9700\u5c3d\u65e9\u8bc4\u4f30\u662f\u5426\u4f1a\u89e6\u53d1\u5883\u5185\u5916\u7ecf\u8425\u8005\u96c6\u4e2d\u7533\u62a5\u4e49\u52a1\u3002<\/p>\n

\"Audrey<\/p>\n

\u5979\u4ee5\u7f8e\u56fd\u4e3a\u4f8b\uff0c\u7f8e\u56fd\u662flicense-out\u4ea4\u6613\u7684\u91cd\u8981\u76ee\u6807\u5e02\u573a\uff0c\u4e2d\u56fd\u836f\u4f01\u5bf9\u4e8e\u7f8e\u56fd\u4f9d\u636e\u300a\u54c8\u7279\u2011\u65af\u79d1\u7279\u2011\u7f57\u8fea\u8bfa\u53cd\u6258\u62c9\u65af\u6539\u8fdb\u6cd5\u300b\uff08HSR \u6cd5\u6848\uff09\u5efa\u7acb\u7684\u53cd\u5784\u65ad\u5ba1\u67e5\u673a\u5236\uff0c\u5e94\u4e88\u4ee5\u9ad8\u5ea6\u91cd\u89c6\u3002\u674e\u96e8\u6fdb\u8bf4\uff1a\u201c\u5982\u679c\u4ea4\u6613\u5305\u542b\u7814\u53d1\u3001\u751f\u4ea7\u3001\u9500\u552e\u5b9a\u4ef7\u7b49\u6838\u5fc3\u5546\u4e1a\u6743\u5229\u7684\u8f6c\u8ba9\uff0c\u5373\u4fbf\u4e0d\u6d89\u53ca\u80a1\u6743\u53d8\u66f4\uff0c\u4ecd\u53ef\u80fd\u88ab\u8ba4\u5b9a\u4e3a\u5b9e\u8d28\u6027\u7684\u63a7\u5236\u6743\u8f6c\u79fb\uff0c\u4ece\u800c\u89e6\u53d1HSR\u7533\u62a5\u4e49\u52a1\u3002\u6211\u4eec\u5efa\u8bae\u5e94\u5c3d\u65e9\u8bc4\u4f30\u76f8\u5173\u4ea4\u6613\u53ef\u80fd\u5bf9\u5e02\u573a\u7ade\u4e89\u9020\u6210\u7684\u5f71\u54cd\u3002\u201d<\/p>\n

\u91d1\u675c\u6240\u9a7b\u5317\u4eac\u5408\u4f19\u4eba\u5218\u6210\u8bf4\uff1a\u201c\u4ea4\u6613\u7684\u90e8\u7f72\u5b89\u6392\u3001\u9644\u5c5e\u6761\u6b3e\u3001\u4e0d\u7ade\u4e89\u6761\u6b3e\u3001\u72ec\u5bb6\u8bb8\u53ef\u90fd\u8981\u4ece\u53cd\u5784\u65ad\u89d2\u5ea6\u8bc4\u4f30\u5408\u89c4\u6027\u7684\u95ee\u9898\u3002\u201d\u5bf9\u4e8e\u89e6\u53d1\u4e2d\u56fd\u7ecf\u8425\u8005\u96c6\u4e2d\u7533\u62a5\u7684\u4ea4\u6613\uff0c\u82e5\u4ea4\u6613\u7b26\u5408\u7b80\u6613\u7a0b\u5e8f\u6761\u4ef6\uff0c\u5ba1\u6279\u5468\u671f\u901a\u5e38\u8f83\u77ed\uff0c\u4e00\u822c\u5728\u4e00\u81f3\u4e24\u4e2a\u6708\u5185\u5373\u53ef\u83b7\u5f97\u6279\u51c6\u3002\u5bf9\u4e8e\u9700\u8981\u666e\u901a\u7a0b\u5e8f\u7533\u62a5\u7684\u6848\u4ef6\uff0c\u5219\u9700\u8981\u66f4\u957f\u65f6\u95f4\u3002<\/p>\n

\u4eba\u624d\u51b3\u5b9a\u6210\u8d25<\/strong><\/span><\/h2>\n

\u6731\u654f\u5efa\u8bae\u836f\u4f01\u8be5\u5c3d\u65e9\u8ba9\u5f8b\u5e08\u4ecb\u5165license-out\u4ea4\u6613\uff0c\u201c\u6700\u597d\u5728 term sheet\u9636\u6bb5\u5c31\u5f15\u5165\u5177\u5907\u751f\u7269\u533b\u836f\u8de8\u5883\u4ea4\u6613\u7ecf\u9a8c\u7684\u5f8b\u5e08\u56e2\u961f\uff0c\u8ba9\u6cd5\u5f8b\u4e13\u4e1a\u5efa\u8bae\u76f4\u63a5\u5d4c\u5165\u4ea4\u6613\u7ed3\u6784\u8bbe\u8ba1\u548c\u5173\u952e\u6761\u6b3e\u5236\u5b9a\u8fc7\u7a0b\u3002\u201d\u4ed6\u8865\u5145\uff0c\u6cd5\u52a1\u5e94\u63d0\u524d\u660e\u786e\u6cd5\u5f8b\u670d\u52a1\u8986\u76d6\u7684\u9886\u57df\uff0c\u5e76\u6839\u636e\u4ea4\u6613\u7279\u70b9\u7ec4\u5efa\u5305\u542b\u4e0d\u540c\u9886\u57df\u4e13\u5bb6\u7684\u56e2\u961f\uff0c\u4ece\u9879\u76ee\u65e9\u671f\u5373\u5236\u5b9a\u5b8c\u6574\u9879\u76ee\u8ba1\u5212\uff0c\u800c\u4e0d\u662f\u201c\u8d70\u4e00\u6b65\u770b\u4e00\u6b65\u201d\u3002<\/p>\n

\u5218\u5143\u971e\u5219\u5173\u6ce8\u5230\u836f\u4f01\u5185\u90e8\u7ec4\u7ec7\u7ed3\u6784\u5e26\u6765\u7684\u6311\u6218\u3002\u5979\u6307\u51fa\uff0c\u76ee\u524d\u8bb8\u591a\u56fd\u5185\u4f01\u4e1a\u5c06\u6cd5\u52a1\u4e0eIP\u56e2\u961f\u5206\u8bbe\uff0c\u8fd9\u79cd\u6a21\u5f0f\u6613\u5bfc\u81f4\u6743\u8d23\u6a21\u7cca\u4e0e\u534f\u4f5c\u4e0d\u7545\u3002\u5979\u5efa\u8bae\u4f01\u4e1a\u5e94\u6253\u7834\u90e8\u95e8\u58c1\u5792\uff0c\u5f3a\u5316\u56e2\u961f\u534f\u540c\uff0c\u5c06\u4e13\u4e1a\u4e8b\u52a1\u4ea4\u7531\u6700\u64c5\u957f\u7684\u56e2\u961f\u5904\u7406\u3002<\/p>\n

\u800c\u5728\u8fd9\u4e00\u8f6elicense-out\u4e0e\u5e76\u8d2d\u7684\u51fa\u6d77\u70ed\u6f6e\u4e2d\uff0c\u674e\u7a0b\u63d0\u9192\u4e2d\u56fd\u4f01\u4e1a\u5728\u4eab\u53d7\u7ea2\u5229\u7684\u540c\u65f6\uff0c\u4e5f\u987b\u76f4\u9762\u56fd\u9645\u5e02\u573a\u7ade\u4e89\u4e0e\u6cd5\u5f8b\u653f\u7b56\u7684\u6311\u6218\uff0c\u4f8b\u5982\u6f5c\u5728\u8de8\u5883\u4e89\u8bae\u3002\u4e2d\u56fd\u4f01\u4e1a\u662f\u5426\u5df2\u505a\u597d\u5e94\u5bf9\u5168\u7403\u7ade\u4e89\u6311\u6218\u7684\u51c6\u5907\uff1f\u4ed6\u5766\u8a00\uff1a\u201c\u76ee\u524d\u8fd8\u4e0d\u786e\u5b9a\uff0c\u56e0\u4e3a\u5f88\u591a\u4ea4\u6613\u90fd\u662f\u5728\u8fc7\u53bb\u4e24\u4e09\u5e74\u7b7e\u8ba2\u7684\uff0c\u5e0c\u671b\u4f17\u591a\u4f01\u4e1a\u80fd\u5c3d\u65e9\u505a\u597d\u5e94\u5bf9\u51c6\u5907\u3002\u201d<\/p>\n

\"Richard<\/p>\n

\u201c\u4e2d\u56fd\u900f\u8fc7BD\uff08\u5546\u52a1\u62d3\u5c55\uff09\u4ea4\u6613\u53bb\u51fa\u6d77\u7684\u8d8b\u52bf\u4e0d\u4f1a\u505c\u4e0b\u6765\uff0c\u80af\u5b9a\u4f1a\u7ee7\u7eed\u589e\u52a0\u3002\u56e0\u6b64\uff0c\u4e0d\u4ec5\u662f\u6cd5\u52a1\u56e2\u961f\uff0c\u6574\u4e2a\u516c\u53f8\u7ba1\u7406\u5c42\u90fd\u5fc5\u987b\u610f\u8bc6\u5230\uff0c\u65e2\u7136\u8981\u8d5a\u51fa\u6d77\u7684\u94b1\uff0c\u5c31\u610f\u5473\u7740\u52a0\u5165\u4e00\u573a\u56fd\u9645\u7ade\u4e89\uff0c\u201d\u4ed6\u8865\u5145\u8bf4\uff0c\u201c\u4f01\u4e1a\u5fc5\u987b\u5728\u6cd5\u5f8b\u4e0e\u76d1\u7ba1\u5e94\u5bf9\u3001\u5fc3\u7406\u51c6\u5907\u3001\u4eba\u624d\u914d\u5907\u53ca\u5185\u7f6e\u7cfb\u7edf\u7b49\u591a\u65b9\u9762\u505a\u597d\u5168\u9762\u51c6\u5907\u3002\u5426\u5219\uff0c\u5f88\u53ef\u80fd\u4f1a\u63aa\u624b\u4e0d\u53ca\u3002\u201d<\/p>\n

[\/ihc-hide-content]<\/p>\n","protected":false},"excerpt":{"rendered":"

\u968f\u7740\u9876\u5c16\u4e2d\u56fd\u836f\u4f01\u4ece\u4eff\u5236\u836f\u5411\u521b\u65b0\u836f\u6218\u7565\u8f6c\u578b\uff0c\u5bf9\u5916\u6388\u6743\uff08lice<\/p>\n","protected":false},"author":13501,"featured_media":612050,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"sfsi_plus_gutenberg_text_before_share":"","sfsi_plus_gutenberg_show_text_before_share":"","sfsi_plus_gutenberg_icon_type":"","sfsi_plus_gutenberg_icon_alignemt":"","sfsi_plus_gutenburg_max_per_row":"","meta-author":"","footnotes":""},"categories":[169623,4590,75,252,407],"tags":[171466,46633,167223,173926,173923,173931,173930,129127,157620,165658,1145,3007,173924,173927,127766,146099,173928,4489,1927,6580,171465,2525,173929,167224,6613,173925],"class_list":["post-612125","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-2025-jul-aug-zh","category-4590","category-china-business-law-journal-zh-hans","category-252","category-407","tag-alan-tamarelli-zh-hans","tag-ma-zh-hans","tag-167223","tag-173926","tag-173923","tag-173931","tag-173930","tag-129127","tag-157620","tag-165658","tag-1145","tag-3007","tag-173924","tag-173927","tag-127766","tag-146099","tag-173928","tag-4489","tag-intellectual-property-zh","tag-6580","tag-171465","tag-2525","tag-173929","tag-167224","tag-6613","tag-173925"],"acf":[],"yoast_head":"\n\u4e2d\u56fd\u521b\u65b0\u533b\u836f\u5bf9\u5916\u6388\u6743\u4ea4\u6613\u7684\u89c4\u907f\u6307\u5357 | \u300a\u5546\u6cd5\u300b\uff5cLaw.asia<\/title>\n<meta name=\"description\" content=\"\u5c31\u5728\u672a\u6765\u4e24\u5230\u4e09\u5e74\uff0c\u201c\u4e13\u5229\u60ac\u5d16\u201d\u7684\u6311\u6218\u5373\u5c06\u4e34\u5230\u5168\u7403\u5236\u836f\u5de8\u5934\uff0c\u6570\u4ee5\u767e\u4ebf\u7f8e\u5143\u8ba1\u7684\u660e\u661f\u836f\u7269\u5c06\u8fce\u6765\u4eff\u5236\u836f\u7684\u6fc0\u70c8\u7ade\u4e89\u3002\u9762\u5bf9\u91cd\u91cd\u538b\u529b\u7684\u8de8\u56fd\u836f\u4f01\uff0c\u4e0d\u7ea6\u800c\u540c\u5730\u5c06\u76ee\u5149\u6295\u5411\u4e86\u4e1c\u65b9\u2014\u2014\u5728\u4e2d\u56fd\u641c\u5bfb\u4e0b\u4e00\u4ee3\u201c\u91cd\u78c5\u70b8\u5f39\u836f\u7269\u201d\uff08blockbuster drug\uff09\uff0c\u5e76\u79ef\u6781\u6536\u8d2d\u65e9\u671f\u4e34\u5e8a\u9636\u6bb5\u7684\u521b\u65b0\u836f\u7269\u3002\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/law-asia.visibleone.dev\/zh-hans\/china-pharma-out-licensing-deals\/\" \/>\n<meta property=\"og:locale\" content=\"zh_CN\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"\u4e2d\u56fd\u521b\u65b0\u533b\u836f\u5bf9\u5916\u6388\u6743\u4ea4\u6613\u7684\u89c4\u907f\u6307\u5357 | \u300a\u5546\u6cd5\u300b\uff5cLaw.asia\" \/>\n<meta property=\"og:description\" content=\"\u5c31\u5728\u672a\u6765\u4e24\u5230\u4e09\u5e74\uff0c\u201c\u4e13\u5229\u60ac\u5d16\u201d\u7684\u6311\u6218\u5373\u5c06\u4e34\u5230\u5168\u7403\u5236\u836f\u5de8\u5934\uff0c\u6570\u4ee5\u767e\u4ebf\u7f8e\u5143\u8ba1\u7684\u660e\u661f\u836f\u7269\u5c06\u8fce\u6765\u4eff\u5236\u836f\u7684\u6fc0\u70c8\u7ade\u4e89\u3002\u9762\u5bf9\u91cd\u91cd\u538b\u529b\u7684\u8de8\u56fd\u836f\u4f01\uff0c\u4e0d\u7ea6\u800c\u540c\u5730\u5c06\u76ee\u5149\u6295\u5411\u4e86\u4e1c\u65b9\u2014\u2014\u5728\u4e2d\u56fd\u641c\u5bfb\u4e0b\u4e00\u4ee3\u201c\u91cd\u78c5\u70b8\u5f39\u836f\u7269\u201d\uff08blockbuster drug\uff09\uff0c\u5e76\u79ef\u6781\u6536\u8d2d\u65e9\u671f\u4e34\u5e8a\u9636\u6bb5\u7684\u521b\u65b0\u836f\u7269\u3002\" \/>\n<meta property=\"og:url\" content=\"https:\/\/law-asia.visibleone.dev\/zh-hans\/china-pharma-out-licensing-deals\/\" \/>\n<meta property=\"og:site_name\" content=\"Law.asia\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/AsiaBusinessLaw\/\" \/>\n<meta property=\"article:published_time\" content=\"2025-09-10T09:49:43+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-10-16T03:14:37+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/law-asia.visibleone.dev\/wp-content\/uploads\/2025\/09\/Out-licensing-is-in.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"900\" \/>\n\t<meta property=\"og:image:height\" content=\"600\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Website team 05\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@ablj_insights\" \/>\n<meta name=\"twitter:site\" content=\"@ablj_insights\" \/>\n<meta name=\"twitter:label1\" content=\"\u4f5c\u8005\" \/>\n\t<meta name=\"twitter:data1\" content=\"Website team 05\" \/>\n\t<meta name=\"twitter:label2\" content=\"\u9884\u8ba1\u9605\u8bfb\u65f6\u95f4\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/law-asia.visibleone.dev\\\/zh-hans\\\/china-pharma-out-licensing-deals\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/law-asia.visibleone.dev\\\/zh-hans\\\/china-pharma-out-licensing-deals\\\/\"},\"author\":{\"name\":\"Website team 05\",\"@id\":\"https:\\\/\\\/law.asia\\\/#\\\/schema\\\/person\\\/5622fa84f077484b1195f2f445d9b8e9\"},\"headline\":\"\u201c\u836f\u201d\u8dc3\u9f99\u95e8\",\"datePublished\":\"2025-09-10T09:49:43+00:00\",\"dateModified\":\"2025-10-16T03:14:37+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/law-asia.visibleone.dev\\\/zh-hans\\\/china-pharma-out-licensing-deals\\\/\"},\"wordCount\":42,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/law.asia\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/law-asia.visibleone.dev\\\/zh-hans\\\/china-pharma-out-licensing-deals\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/law-asia.visibleone.dev\\\/wp-content\\\/uploads\\\/2025\\\/09\\\/Out-licensing-is-in.jpg\",\"keywords\":[\"Alan Tamarelli\",\"M&A\",\"\u4e09\u751f\u5236\u836f\",\"\u4e13\u5229\u60ac\u5d16\",\"\u4e2d\u56fd\u836f\u4f01\",\"\u4e34\u5e8a\u8bd5\u9a8c\",\"\u5168\u7403\u836f\u4f01\",\"\u5218\u5143\u971e\",\"\u5218\u6210\",\"\u521b\u65b0\u836f\",\"\u53cd\u5784\u65ad\",\"\u53cd\u5784\u65ad\u5ba1\u67e5\",\"\u5bf9\u5916\u6388\u6743\u4ea4\u6613\",\"\u6052\u745e\u533b\u836f\",\"\u6731\u654f\",\"\u674e\u7a0b\",\"\u674e\u96e8\u6fdb\",\"\u6c49\u5764\u5f8b\u5e08\u4e8b\u52a1\u6240\",\"\u77e5\u8bc6\u4ea7\u6743\",\"\u79d1\u5f8b\u5f8b\u5e08\u4e8b\u52a1\u6240\",\"\u845b\u5170\u7d20\u53f2\u514b\",\"\u897f\u76df\u65af\u5f8b\u5e08\u4e8b\u52a1\u6240\",\"\u8de8\u5883\u6570\u636e\u5408\u89c4\",\"\u8f89\u745e\",\"\u9053\u53ef\u7279\u5f8b\u5e08\u4e8b\u52a1\u6240\",\"\u91cd\u78c5\u836f\u7269\"],\"articleSection\":[\"2025\u5e747-8\u6708\u520a\",\"\u4e13\u9898\",\"\u5546\u6cd5\",\"\u5546\u6cd5\u5256\u6790\",\"\u680f\u76ee\"],\"inLanguage\":\"zh-CN\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/law-asia.visibleone.dev\\\/zh-hans\\\/china-pharma-out-licensing-deals\\\/#respond\"]}],\"copyrightYear\":\"2025\",\"copyrightHolder\":{\"@id\":\"https:\\\/\\\/law-asia.visibleone.dev\\\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/law-asia.visibleone.dev\\\/zh-hans\\\/china-pharma-out-licensing-deals\\\/\",\"url\":\"https:\\\/\\\/law-asia.visibleone.dev\\\/zh-hans\\\/china-pharma-out-licensing-deals\\\/\",\"name\":\"\u4e2d\u56fd\u521b\u65b0\u533b\u836f\u5bf9\u5916\u6388\u6743\u4ea4\u6613\u7684\u89c4\u907f\u6307\u5357 | \u300a\u5546\u6cd5\u300b\uff5cLaw.asia\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/law.asia\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/law-asia.visibleone.dev\\\/zh-hans\\\/china-pharma-out-licensing-deals\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/law-asia.visibleone.dev\\\/zh-hans\\\/china-pharma-out-licensing-deals\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/law-asia.visibleone.dev\\\/wp-content\\\/uploads\\\/2025\\\/09\\\/Out-licensing-is-in.jpg\",\"datePublished\":\"2025-09-10T09:49:43+00:00\",\"dateModified\":\"2025-10-16T03:14:37+00:00\",\"description\":\"\u5c31\u5728\u672a\u6765\u4e24\u5230\u4e09\u5e74\uff0c\u201c\u4e13\u5229\u60ac\u5d16\u201d\u7684\u6311\u6218\u5373\u5c06\u4e34\u5230\u5168\u7403\u5236\u836f\u5de8\u5934\uff0c\u6570\u4ee5\u767e\u4ebf\u7f8e\u5143\u8ba1\u7684\u660e\u661f\u836f\u7269\u5c06\u8fce\u6765\u4eff\u5236\u836f\u7684\u6fc0\u70c8\u7ade\u4e89\u3002\u9762\u5bf9\u91cd\u91cd\u538b\u529b\u7684\u8de8\u56fd\u836f\u4f01\uff0c\u4e0d\u7ea6\u800c\u540c\u5730\u5c06\u76ee\u5149\u6295\u5411\u4e86\u4e1c\u65b9\u2014\u2014\u5728\u4e2d\u56fd\u641c\u5bfb\u4e0b\u4e00\u4ee3\u201c\u91cd\u78c5\u70b8\u5f39\u836f\u7269\u201d\uff08blockbuster drug\uff09\uff0c\u5e76\u79ef\u6781\u6536\u8d2d\u65e9\u671f\u4e34\u5e8a\u9636\u6bb5\u7684\u521b\u65b0\u836f\u7269\u3002\",\"inLanguage\":\"zh-CN\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/law-asia.visibleone.dev\\\/zh-hans\\\/china-pharma-out-licensing-deals\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"zh-CN\",\"@id\":\"https:\\\/\\\/law-asia.visibleone.dev\\\/zh-hans\\\/china-pharma-out-licensing-deals\\\/#primaryimage\",\"url\":\"https:\\\/\\\/law-asia.visibleone.dev\\\/wp-content\\\/uploads\\\/2025\\\/09\\\/Out-licensing-is-in.jpg\",\"contentUrl\":\"https:\\\/\\\/law-asia.visibleone.dev\\\/wp-content\\\/uploads\\\/2025\\\/09\\\/Out-licensing-is-in.jpg\",\"width\":900,\"height\":600,\"caption\":\"China Pharma Out-Licensing Deals\"},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/law.asia\\\/#website\",\"url\":\"https:\\\/\\\/law.asia\\\/\",\"name\":\"Law.asia\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/law.asia\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/law.asia\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"zh-CN\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/law.asia\\\/#organization\",\"name\":\"Law.asia\",\"url\":\"https:\\\/\\\/law.asia\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"zh-CN\",\"@id\":\"https:\\\/\\\/law.asia\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/law.asia\\\/wp-content\\\/uploads\\\/2020\\\/10\\\/LAWDOTASIA-LOGO-152.png\",\"contentUrl\":\"https:\\\/\\\/law.asia\\\/wp-content\\\/uploads\\\/2020\\\/10\\\/LAWDOTASIA-LOGO-152.png\",\"width\":152,\"height\":152,\"caption\":\"Law.asia\"},\"image\":{\"@id\":\"https:\\\/\\\/law.asia\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/AsiaBusinessLaw\\\/\",\"https:\\\/\\\/x.com\\\/ablj_insights\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/law.asia\\\/#\\\/schema\\\/person\\\/5622fa84f077484b1195f2f445d9b8e9\",\"name\":\"Website team 05\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"zh-CN\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/22eb04a61cec5137c915a781f96eb7ac992441defcf44aa5c46fd2fd4e6af2c3?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/22eb04a61cec5137c915a781f96eb7ac992441defcf44aa5c46fd2fd4e6af2c3?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/22eb04a61cec5137c915a781f96eb7ac992441defcf44aa5c46fd2fd4e6af2c3?s=96&d=mm&r=g\",\"caption\":\"Website team 05\"},\"url\":\"https:\\\/\\\/law-asia.visibleone.dev\\\/zh-hans\\\/author\\\/johnmanson\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"\u4e2d\u56fd\u521b\u65b0\u533b\u836f\u5bf9\u5916\u6388\u6743\u4ea4\u6613\u7684\u89c4\u907f\u6307\u5357 | \u300a\u5546\u6cd5\u300b\uff5cLaw.asia","description":"\u5c31\u5728\u672a\u6765\u4e24\u5230\u4e09\u5e74\uff0c\u201c\u4e13\u5229\u60ac\u5d16\u201d\u7684\u6311\u6218\u5373\u5c06\u4e34\u5230\u5168\u7403\u5236\u836f\u5de8\u5934\uff0c\u6570\u4ee5\u767e\u4ebf\u7f8e\u5143\u8ba1\u7684\u660e\u661f\u836f\u7269\u5c06\u8fce\u6765\u4eff\u5236\u836f\u7684\u6fc0\u70c8\u7ade\u4e89\u3002\u9762\u5bf9\u91cd\u91cd\u538b\u529b\u7684\u8de8\u56fd\u836f\u4f01\uff0c\u4e0d\u7ea6\u800c\u540c\u5730\u5c06\u76ee\u5149\u6295\u5411\u4e86\u4e1c\u65b9\u2014\u2014\u5728\u4e2d\u56fd\u641c\u5bfb\u4e0b\u4e00\u4ee3\u201c\u91cd\u78c5\u70b8\u5f39\u836f\u7269\u201d\uff08blockbuster drug\uff09\uff0c\u5e76\u79ef\u6781\u6536\u8d2d\u65e9\u671f\u4e34\u5e8a\u9636\u6bb5\u7684\u521b\u65b0\u836f\u7269\u3002","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/law-asia.visibleone.dev\/zh-hans\/china-pharma-out-licensing-deals\/","og_locale":"zh_CN","og_type":"article","og_title":"\u4e2d\u56fd\u521b\u65b0\u533b\u836f\u5bf9\u5916\u6388\u6743\u4ea4\u6613\u7684\u89c4\u907f\u6307\u5357 | \u300a\u5546\u6cd5\u300b\uff5cLaw.asia","og_description":"\u5c31\u5728\u672a\u6765\u4e24\u5230\u4e09\u5e74\uff0c\u201c\u4e13\u5229\u60ac\u5d16\u201d\u7684\u6311\u6218\u5373\u5c06\u4e34\u5230\u5168\u7403\u5236\u836f\u5de8\u5934\uff0c\u6570\u4ee5\u767e\u4ebf\u7f8e\u5143\u8ba1\u7684\u660e\u661f\u836f\u7269\u5c06\u8fce\u6765\u4eff\u5236\u836f\u7684\u6fc0\u70c8\u7ade\u4e89\u3002\u9762\u5bf9\u91cd\u91cd\u538b\u529b\u7684\u8de8\u56fd\u836f\u4f01\uff0c\u4e0d\u7ea6\u800c\u540c\u5730\u5c06\u76ee\u5149\u6295\u5411\u4e86\u4e1c\u65b9\u2014\u2014\u5728\u4e2d\u56fd\u641c\u5bfb\u4e0b\u4e00\u4ee3\u201c\u91cd\u78c5\u70b8\u5f39\u836f\u7269\u201d\uff08blockbuster drug\uff09\uff0c\u5e76\u79ef\u6781\u6536\u8d2d\u65e9\u671f\u4e34\u5e8a\u9636\u6bb5\u7684\u521b\u65b0\u836f\u7269\u3002","og_url":"https:\/\/law-asia.visibleone.dev\/zh-hans\/china-pharma-out-licensing-deals\/","og_site_name":"Law.asia","article_publisher":"https:\/\/www.facebook.com\/AsiaBusinessLaw\/","article_published_time":"2025-09-10T09:49:43+00:00","article_modified_time":"2025-10-16T03:14:37+00:00","og_image":[{"width":900,"height":600,"url":"https:\/\/law-asia.visibleone.dev\/wp-content\/uploads\/2025\/09\/Out-licensing-is-in.jpg","type":"image\/jpeg"}],"author":"Website team 05","twitter_card":"summary_large_image","twitter_creator":"@ablj_insights","twitter_site":"@ablj_insights","twitter_misc":{"\u4f5c\u8005":"Website team 05","\u9884\u8ba1\u9605\u8bfb\u65f6\u95f4":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/law-asia.visibleone.dev\/zh-hans\/china-pharma-out-licensing-deals\/#article","isPartOf":{"@id":"https:\/\/law-asia.visibleone.dev\/zh-hans\/china-pharma-out-licensing-deals\/"},"author":{"name":"Website team 05","@id":"https:\/\/law.asia\/#\/schema\/person\/5622fa84f077484b1195f2f445d9b8e9"},"headline":"\u201c\u836f\u201d\u8dc3\u9f99\u95e8","datePublished":"2025-09-10T09:49:43+00:00","dateModified":"2025-10-16T03:14:37+00:00","mainEntityOfPage":{"@id":"https:\/\/law-asia.visibleone.dev\/zh-hans\/china-pharma-out-licensing-deals\/"},"wordCount":42,"commentCount":0,"publisher":{"@id":"https:\/\/law.asia\/#organization"},"image":{"@id":"https:\/\/law-asia.visibleone.dev\/zh-hans\/china-pharma-out-licensing-deals\/#primaryimage"},"thumbnailUrl":"https:\/\/law-asia.visibleone.dev\/wp-content\/uploads\/2025\/09\/Out-licensing-is-in.jpg","keywords":["Alan Tamarelli","M&A","\u4e09\u751f\u5236\u836f","\u4e13\u5229\u60ac\u5d16","\u4e2d\u56fd\u836f\u4f01","\u4e34\u5e8a\u8bd5\u9a8c","\u5168\u7403\u836f\u4f01","\u5218\u5143\u971e","\u5218\u6210","\u521b\u65b0\u836f","\u53cd\u5784\u65ad","\u53cd\u5784\u65ad\u5ba1\u67e5","\u5bf9\u5916\u6388\u6743\u4ea4\u6613","\u6052\u745e\u533b\u836f","\u6731\u654f","\u674e\u7a0b","\u674e\u96e8\u6fdb","\u6c49\u5764\u5f8b\u5e08\u4e8b\u52a1\u6240","\u77e5\u8bc6\u4ea7\u6743","\u79d1\u5f8b\u5f8b\u5e08\u4e8b\u52a1\u6240","\u845b\u5170\u7d20\u53f2\u514b","\u897f\u76df\u65af\u5f8b\u5e08\u4e8b\u52a1\u6240","\u8de8\u5883\u6570\u636e\u5408\u89c4","\u8f89\u745e","\u9053\u53ef\u7279\u5f8b\u5e08\u4e8b\u52a1\u6240","\u91cd\u78c5\u836f\u7269"],"articleSection":["2025\u5e747-8\u6708\u520a","\u4e13\u9898","\u5546\u6cd5","\u5546\u6cd5\u5256\u6790","\u680f\u76ee"],"inLanguage":"zh-CN","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/law-asia.visibleone.dev\/zh-hans\/china-pharma-out-licensing-deals\/#respond"]}],"copyrightYear":"2025","copyrightHolder":{"@id":"https:\/\/law-asia.visibleone.dev\/#organization"}},{"@type":"WebPage","@id":"https:\/\/law-asia.visibleone.dev\/zh-hans\/china-pharma-out-licensing-deals\/","url":"https:\/\/law-asia.visibleone.dev\/zh-hans\/china-pharma-out-licensing-deals\/","name":"\u4e2d\u56fd\u521b\u65b0\u533b\u836f\u5bf9\u5916\u6388\u6743\u4ea4\u6613\u7684\u89c4\u907f\u6307\u5357 | \u300a\u5546\u6cd5\u300b\uff5cLaw.asia","isPartOf":{"@id":"https:\/\/law.asia\/#website"},"primaryImageOfPage":{"@id":"https:\/\/law-asia.visibleone.dev\/zh-hans\/china-pharma-out-licensing-deals\/#primaryimage"},"image":{"@id":"https:\/\/law-asia.visibleone.dev\/zh-hans\/china-pharma-out-licensing-deals\/#primaryimage"},"thumbnailUrl":"https:\/\/law-asia.visibleone.dev\/wp-content\/uploads\/2025\/09\/Out-licensing-is-in.jpg","datePublished":"2025-09-10T09:49:43+00:00","dateModified":"2025-10-16T03:14:37+00:00","description":"\u5c31\u5728\u672a\u6765\u4e24\u5230\u4e09\u5e74\uff0c\u201c\u4e13\u5229\u60ac\u5d16\u201d\u7684\u6311\u6218\u5373\u5c06\u4e34\u5230\u5168\u7403\u5236\u836f\u5de8\u5934\uff0c\u6570\u4ee5\u767e\u4ebf\u7f8e\u5143\u8ba1\u7684\u660e\u661f\u836f\u7269\u5c06\u8fce\u6765\u4eff\u5236\u836f\u7684\u6fc0\u70c8\u7ade\u4e89\u3002\u9762\u5bf9\u91cd\u91cd\u538b\u529b\u7684\u8de8\u56fd\u836f\u4f01\uff0c\u4e0d\u7ea6\u800c\u540c\u5730\u5c06\u76ee\u5149\u6295\u5411\u4e86\u4e1c\u65b9\u2014\u2014\u5728\u4e2d\u56fd\u641c\u5bfb\u4e0b\u4e00\u4ee3\u201c\u91cd\u78c5\u70b8\u5f39\u836f\u7269\u201d\uff08blockbuster drug\uff09\uff0c\u5e76\u79ef\u6781\u6536\u8d2d\u65e9\u671f\u4e34\u5e8a\u9636\u6bb5\u7684\u521b\u65b0\u836f\u7269\u3002","inLanguage":"zh-CN","potentialAction":[{"@type":"ReadAction","target":["https:\/\/law-asia.visibleone.dev\/zh-hans\/china-pharma-out-licensing-deals\/"]}]},{"@type":"ImageObject","inLanguage":"zh-CN","@id":"https:\/\/law-asia.visibleone.dev\/zh-hans\/china-pharma-out-licensing-deals\/#primaryimage","url":"https:\/\/law-asia.visibleone.dev\/wp-content\/uploads\/2025\/09\/Out-licensing-is-in.jpg","contentUrl":"https:\/\/law-asia.visibleone.dev\/wp-content\/uploads\/2025\/09\/Out-licensing-is-in.jpg","width":900,"height":600,"caption":"China Pharma Out-Licensing Deals"},{"@type":"WebSite","@id":"https:\/\/law.asia\/#website","url":"https:\/\/law.asia\/","name":"Law.asia","description":"","publisher":{"@id":"https:\/\/law.asia\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/law.asia\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"zh-CN"},{"@type":"Organization","@id":"https:\/\/law.asia\/#organization","name":"Law.asia","url":"https:\/\/law.asia\/","logo":{"@type":"ImageObject","inLanguage":"zh-CN","@id":"https:\/\/law.asia\/#\/schema\/logo\/image\/","url":"https:\/\/law.asia\/wp-content\/uploads\/2020\/10\/LAWDOTASIA-LOGO-152.png","contentUrl":"https:\/\/law.asia\/wp-content\/uploads\/2020\/10\/LAWDOTASIA-LOGO-152.png","width":152,"height":152,"caption":"Law.asia"},"image":{"@id":"https:\/\/law.asia\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/AsiaBusinessLaw\/","https:\/\/x.com\/ablj_insights"]},{"@type":"Person","@id":"https:\/\/law.asia\/#\/schema\/person\/5622fa84f077484b1195f2f445d9b8e9","name":"Website team 05","image":{"@type":"ImageObject","inLanguage":"zh-CN","@id":"https:\/\/secure.gravatar.com\/avatar\/22eb04a61cec5137c915a781f96eb7ac992441defcf44aa5c46fd2fd4e6af2c3?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/22eb04a61cec5137c915a781f96eb7ac992441defcf44aa5c46fd2fd4e6af2c3?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/22eb04a61cec5137c915a781f96eb7ac992441defcf44aa5c46fd2fd4e6af2c3?s=96&d=mm&r=g","caption":"Website team 05"},"url":"https:\/\/law-asia.visibleone.dev\/zh-hans\/author\/johnmanson\/"}]}},"_links":{"self":[{"href":"https:\/\/law-asia.visibleone.dev\/zh-hans\/wp-json\/wp\/v2\/posts\/612125","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/law-asia.visibleone.dev\/zh-hans\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/law-asia.visibleone.dev\/zh-hans\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/law-asia.visibleone.dev\/zh-hans\/wp-json\/wp\/v2\/users\/13501"}],"replies":[{"embeddable":true,"href":"https:\/\/law-asia.visibleone.dev\/zh-hans\/wp-json\/wp\/v2\/comments?post=612125"}],"version-history":[{"count":0,"href":"https:\/\/law-asia.visibleone.dev\/zh-hans\/wp-json\/wp\/v2\/posts\/612125\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/law-asia.visibleone.dev\/zh-hans\/wp-json\/wp\/v2\/media\/612050"}],"wp:attachment":[{"href":"https:\/\/law-asia.visibleone.dev\/zh-hans\/wp-json\/wp\/v2\/media?parent=612125"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/law-asia.visibleone.dev\/zh-hans\/wp-json\/wp\/v2\/categories?post=612125"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/law-asia.visibleone.dev\/zh-hans\/wp-json\/wp\/v2\/tags?post=612125"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}